Fiduciary Trust CO Sage Therapeutics, Inc. Transaction History

Fiduciary Trust CO

$6.98 Billion
Q3 2024

A detailed history of Fiduciary Trust CO transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Fiduciary Trust CO holds 26,335 shares of SAGE stock, worth $143,262. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,335

Previous 26,335 -0.0%

Holding current value

$143,262

Previous $285,000 33.68%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$18.62 - $26.95 $8,192 - $11,858	440 Added 1.7%	26,335 $493,000
Q4 2023 Feb 12, 2024	SELL	$17.1 - $22.26 $342 - $445	-20 Reduced 0.08%	25,895 $561,000
Q2 2023 Aug 01, 2023	SELL	$40.65 - $59.54 $1,016 - $1,488	-25 Reduced 0.1%	25,915 $1.22 Million
Q3 2022 Nov 14, 2022	SELL	$32.28 - $43.27 $1,614 - $2,163	-50 Reduced 0.19%	25,940 $1.02 Million
Q4 2021 Feb 14, 2022	SELL	$37.06 - $47.11 $370 - $471	-10 Reduced 0.04%	25,990 $1.11 Million
Q3 2021 Nov 12, 2021	BUY	$40.26 - $57.37 $14,091 - $20,079	350 Added 1.36%	26,000 $1.15 Million
Q1 2021 May 19, 2021	SELL	$70.65 - $96.76 $1,766 - $2,419	-25 Reduced 0.1%	25,650 $1.92 Million
Q3 2020 Nov 13, 2020	SELL	$41.13 - $62.45 $2,056 - $3,122	-50 Reduced 0.19%	25,675 $1.57 Million
Q2 2020 Aug 13, 2020	BUY	$25.95 - $43.15 $8,433 - $14,023	325 Added 1.28%	25,725 $1.07 Million
Q3 2019 Nov 12, 2019	SELL	$140.29 - $189.96 $2,384 - $3,229	-17 Reduced 0.07%	25,400 $3.56 Million
Q1 2019 May 07, 2019	BUY	$89.33 - $163.65 $1,518 - $2,782	17 Added 0.07%	25,417 $4.04 Million
Q4 2018 Jan 29, 2019	BUY	$81.94 - $139.71 $163,880 - $279,420	2,000 Added 8.55%	25,400 $2.43 Million
Q1 2018 May 08, 2018	BUY	$152.15 - $192.33 $652,571 - $824,903	4,289 Added 22.44%	23,400 $3.77 Million
Q4 2017 Jan 29, 2018	BUY	$60.72 - $167.34 $207,905 - $572,972	3,424 Added 21.83%	19,111 $3.15 Million
Q3 2017 Nov 02, 2017	BUY	$61.4 - $88.52 $963,181 - $1.39 Million	15,687	15,687 $977,000

Others Institutions Holding SAGE

# of Institutions

198

Shares Held

46.5M

Call Options Held

402K

Put Options Held

209K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $323M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiduciary Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Fiduciary Trust CO with notifications on news.

Account

Fiduciary Trust CO Sage Therapeutics, Inc. Transaction History